Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (KAW 2015.0278)
The Strategic Research Program in Diabetes at Umeå University
Kempestiftelserna, Sweden (SMK-1863)
Received: 22 September 2021
Accepted: 6 December 2021
First Online: 23 December 2021
: HE is a cofounder, shareholder, and consultant of the unlisted biotech company Betagenon AB. All other authors declare no competing interests.